Anemia in children with chronic kidney disease

Nature Reviews Nephrology

Volumn 7, Issue 11, 2011, Pages 635-641

  Atkinson, Meredith A ^a   Furth, Susan L ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ADVERSE OUTCOME; ANEMIA; ARTICLE; BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; DIALYSIS; DOSE RESPONSE; DRUG CLEARANCE; DRUG HALF LIFE; DYSERYTHROPOIESIS; ERYTHROPOIESIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERPARATHYROIDISM; INFLAMMATION; IRON DEFICIENCY; IRON INTAKE; IRON THERAPY; MORBIDITY; MORTALITY; NUTRITIONAL DEFICIENCY; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; TREATMENT RESPONSE; UREMIA;

ANEMIA; CHILD; COMORBIDITY; ERYTHROPOIETIN; HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 80255137113     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2011.115     Document Type: Article

References (66)

1. Mitsnefes, M. M. et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J. Pediatr. 149, 671-675 (2006).
2. Schaefer, F. Cardiac disease in children with mild to moderate chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 17, 292-297 (2008).
3. Amaral, S. et al. Association of mortality and hospitalization with achievement of adult hemoglobin targets in adolescents maintained on hemodialysis. J. Am. Soc. Nephrol. 17, 2878-2885 (2006).
4. Furth, S. L. et al. The association of anemia and hypoalbuminemia with accelerated decline in GFR among adolescents with chronic kidney disease. Pediatr. Nephrol. 22, 265-271 (2007).
5. Wühl, E. & Schaefer, F. Therapeutic strategies to slow chronic kidney disease progression. Pediatr. Nephrol. 23, 705-716 (2008).
6. Filler, G., Mylrea, K., Feber, J. & Wong, H. How to define anemia in children with chronic kidney disease? Pediatr. Nephrol. 22, 702-707 (2007).
7. Staples, A. O. et al. Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin. J. Am. Soc. Nephrol. 4, 48-56 (2009).
8. Gerson, A. et al. Anemia and health-related quality of life in adolescents with chronic kidney disease. Am. J. Kidney Dis. 44, 1017-1023 (2004).
9. Hollowell, J. G. et al. Hematological and iron-related analytes-reference data for persons aged 1 year and over: United States, 1988-94. Vital Health Stat. 11 247, 1-156 (2005).
10. Jackson, R. T. Separate hemoglobin standards for blacks and whites: a critical review of the case for separate and unequal hemoglobin standards. Med. Hypotheses 32, 181-189 (1990).
11. Atkinson, M. A. et al. Hemoglobin differences by race in children with CKD. Am. J. Kidney Dis. 55, 1009-1017 (2010).
12. KDOQI: National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am. J. Kidney Dis. 47 (Suppl. 3), S11-S145 (2006).
13. Atkinson, M. A., Martz, K., Warady, B. A. & Neu, A. M. Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediatr. Nephrol. 25, 1699-1706 (2010).
14. Slickers, J., Duquette, P., Hooper, S. & Gipson, D. Clinical predictors of neurocognitive deficits in children with chronic kidney disease. Pediatr. Nephrol. 22, 565-572 (2007).
15. Seikaly, M. G., Salhab, N., Gipson, D., Yiu, V. & Stablein, D. Stature in children with chronic kidney disease: analysis of NAPRTCS database. Pediatr. Nephrol. 21, 793-799 (2006).
16. Amaral, S. et al. Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis. Clin. J. Am. Soc. Nephrol. 3, 759-767 (2008).
17. Warady, B. A. & Ho, M. Morbidity and mortality in children with anemia at initiation of dialysis. Pediatr. Nephrol. 18, 1055-1062 (2003).
18. Mitsnefes, M. et al. Masked hypertension associates with left ventricular hypertrophy in children with CKD. J. Am. Soc. Nephrol. 21, 137-144 (2010).
19. Matteucci, M. C. et al. for the Escape Trial Group. Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J. Am. Soc. Nephrol. 17, 218-226 (2006).
20. Gouva, C., Nikolopoulos, P., Ioannidis, J. P. & Siamopoulos, K. C. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int. 66, 753-760 (2004).
21. Staples, A. O. et al. Association between clinical risk factors and progression of chronic kidney disease in children. Clin. J. Am. Soc. Nephrol. 5, 2172-2179 (2010).
22. Boehm, M. Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease. Pediatr. Nephrol. 22, 1189-1193 (2007).
23. Nangaku, M. & Eckardt, K. U. Pathogenesis of renal anemia. Semin. Nephrol. 26, 261-268 (2006).
24. Goodnough, L. T., Nemeth, E. & Ganz, T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 116, 4754-4761 (2010).
25. Ooi, C. L., Lepage, N., Nieuwenhuys, E., Sharma, A. P. & Filler, G. Pediatric reference intervals for soluble transferrin receptor and transferrin receptor-ferritin index. World J. Pediatr. 5, 122-126 (2009).
26. Looker, A. C., Dallman, P. R., Carroll, M. D., Gunter, E. W. & Johnson, C. L. Prevalence of iron deficiency in the United States. JAMA 277, 973-976 (1997).
27. Braun, J., Lindner, K., Schreiber, M., Heidler, R. A. & Hörl, W. H. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients. Nephrol. Dial. Transplant. 12, 1173-1181 (1997).
28. Kalantar-Zadeh, K., Kalantar-Zadeh, K. & Lee, G. H. The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease? Clin. J. Am. Soc. Nephrol. 1 (Suppl. 1), S9-S18 (2006).
29. Sharma, A. P., McKenna, A. M., Lepage, N., Nieuwenhuys, E. & Filler, G. Relationships among serum iron, inflammation, and body mass index in children. Adv. Pediatr. 56, 135-144 (2009).
30. Girndt, M. et al. Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic haemodialysis patients. Nephrol. Dial. Transplant. 22, 3586-3592 (2007).
31. Goldstein, S. L., Leung, J. C. & Silverstein, D. M. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin. Clin. J. Am. Soc. Nephrol. 1, 979-986 (2006).
32. Pecoits-Filho, R., Sylvestre, L. C. & Stenvinkel, P. Chronic kidney disease and inflammation in pediatric patients: from bench to playground. Pediatr. Nephrol. 20, 714-720 (2005).
33. Sylvestre, L. C. et al. The malnutrition and inflammation axis in pediatric patients with chronic kidney disease. Pediatr. Nephrol. 22, 864-873 (2007).
34. Malyszko, J. & Mysliwiec, M. Hepcidin in anemia and inflammation in chronic kidney disease. Kidney Blood Press. Res. 30, 15-30 (2007).
35. Roy, C. N. & Andrews, N. C. Anemia of inflammation: the hepcidin link. Curr. Opin. Hematol. 12, 107-111 (2005).
36. Swinkels, D. W. & Wetzels, J. F. Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease? Nephrol. Dial. Transplant. 23, 2450-2453 (2008).
37. Kemna, E. H., Tjalsma, H., Willems, H. L. & Swinkels, D. W. Hepcidin: from discovery to differential diagnosis. Haematologica 93, 90-97 (2008).
38. Means, R. T. Hepcidin and cytokines in anaemia. Hematology 9, 357-362 (2004).
39. Nemeth, E. Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias. Adv. Hematol. 2010, 750643 (2010).
40. Zaritsky, J. et al. Hepcidin-a potential novel biomarker for iron status in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 4, 1051-1056 (2009).
41. Bamgbola, O. F. & Kaskel, F. Role of folate deficiency on erythropoietin resistance in pediatric and adolescent patients on chronic dialysis. Pediatr. Nephrol. 20, 1622-1629 (2005).
42. Greenbaum, L. A. Anemia in children with chronic kidney disease. Adv. Chronic Kidney Dis. 12, 385-396 (2005).
43. Kruse, A., Uehlinger, D. E., Gotch, F., Kotanko, P. & Levin, N. W. Red blood cell lifespan, erythropoiesis and hemoglobin control. Contrib. Nephrol. 161, 247-254 (2008).
44. Rao, D. S., Shih, M. S. & Mohini, R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N. Engl. J. Med. 328, 171-175 (1993).
45. Koshy, S. M. & Geary, D. F. Anemia in children with chronic kidney disease. Pediatr. Nephrol. 23, 209-219 (2008).
46. Smith, L. B. et al. Secondary hyperparathyroidism and anemia in children treated by hemodialysis. Am. J. Kidney Dis. 55, 326-334 (2010).
47. Fadrowski, J. J. et al. Hemoglobin decline in children with chronic kidney disease: baseline results from the Chronic Kidney Disease in Children Prospective Cohort Study. Clin. J. Am. Soc. Nephrol. 3, 457-462 (2008).
48. Cruzado, J. M., Rico, J. & Grinyó, J. M. The renin angiotensin system blockade in kidney transplantation: pros and cons. Transpl. Int. 21, 304-313 (2008).
49. Collins, A. J. et al. Excerpts from the United States Renal Data System 2007 annual data report. Am. J. Kidney Dis. 51 (Suppl. 1), S1-S320 (2008).
50. Covic, A. et al. Biosimilars and biopharmaceuticals: what the nephrologists need to know-a position paper by the ERA-EDTA Council. Nephrol. Dial. Transplant. 23, 3731-3737 (2008).
51. Port, R. E. & Mehls, O. Erythropoietin dosing in children with chronic kidney disease: based on body size or on hemoglobin deficit? Pediatr. Nephrol. 24, 435-437 (2009).
52. Bamgbola, O. F., Kaskel, F. J. & Coco, M. Analyses of age, gender and other risk factors of erythropoietin resistance in pediatric and adult dialysis cohorts. Pediatr. Nephrol. 24, 571-579 (2009).
53. Port, R. E., Kiepe, D., Van Guilder, M., Jelliffe, R. W. & Mehls, O. Recombinant human erythropoietin for the treatment of renal anaemia in children: no justification for bodyweight-adjusted dosage. Clin. Pharmacokinet. 43, 57-70 (2004).
54. Foley, R. N. Erythropoietin: physiology and molecular mechanisms. Heart Fail. Rev. 13, 405-414 (2008).
55. Warady, B. A., Arar, M. Y., Lerner, G., Nakanishi, A. M. & Stehman-Breen, C. Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease. Pediatr. Nephrol. 21, 1144-1152 (2006).
56. Schmitt, C. P., Nau, B., Brummer, C., Rosenkranz, J. & Schaefer, F. Increased injection pain with darbepoetin-alpha compared to epoetin-beta in paediatric dialysis patients. Nephrol. Dial. Transplant. 21, 3520-3524 (2006).
57. Singh, A. K. et al. for the CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease. N. Engl. J. Med. 355, 2085-2098 (2006).
58. Drüeke, T. B. et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N. Engl. J. Med. 355, 2071-2084 (2006).
59. Keithi-Reddy, S. R. & Singh, A. K. Hemoglobin target in chronic kidney disease: a pediatric perspective. Pediatr. Nephrol. 24, 431-434 (2009).
60. Kwack, C. & Balakrishnan, V. S. Managing erythropoietin hyporesponsiveness. Semin. Dial. 19, 146-151 (2006).
61. Rossert J., Gassmann-Mayer C., Frei D., McClellan, W. Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients. Nephrol. Dial. Transplant. 22, 794-800 (2007)
62. Bennett C. L., et al. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. Blood 106, 3343-3347 (2005).
63. Morgan, H. E., Gautam, M. & Geary, D. F. Maintenance intravenous iron therapy in pediatric hemodialysis patients. Pediatr. Nephrol. 16, 779-783 (2001).
64. Morgan, H. E., Holt, R. C., Jones, C. A. & Judd, B. A. Intravenous iron treatment in paediatric chronic kidney disease patients not on erythropoietin. Pediatr. Nephrol. 22, 1963-1965 (2007).
65. Agarwal, R. Iron, oxidative stress, and clinical outcomes. Pediatr. Nephrol. 23, 1195-1199 (2008).
66. Fishbane, S. Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines. Semin. Dial. 21, 217-220 (2008).